Iontophoretic administration of dexamethasone sodium phosphate for acute epicondylitis. A randomized, double-blinded, placebo-controlled study.
Am J Sports Med
; 31(2): 189-95, 2003.
Article
en En
| MEDLINE
| ID: mdl-12642251
ABSTRACT
BACKGROUND:
A better treatment modality is needed to control the pain of medial or lateral epicondylitis (tennis elbow).HYPOTHESIS:
Dermal iontophoretic administration of dexamethasone sodium phosphate will be significantly more effective in controlling pain than a placebo in patients with medial or lateral elbow epicondylitis. STUDYDESIGN:
Randomized, double-blinded, placebo-controlled study.METHODS:
On six occasions, 1 to 3 days apart within 15 days, 199 patients with elbow epicondylitis received 40 mA-minutes of either active or placebo treatment.RESULTS:
Dexamethasone produced a significant 23-mm improvement on the 100-mm patient visual analog scale ratings, compared with 14 mm for placebo at 2 days and 24 mm compared with 19 mm at 1 month. More patients treated with dexamethasone than those treated with placebo scored moderate or better on the investigator's global improvement scale (52% versus 33%) at 2 days, but the difference was not significant at 1 month (54% versus 49%). Investigator-rated pain and tenderness scores favored dexamethasone over placebo at 2 days. Patients completing six treatments in 10 days or less had better results than those treated over a longer period.CONCLUSIONS:
Iontophoresis treatment was well tolerated by most patients and was effective in reducing symptoms of epicondylitis at short-term follow-up.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Codo de Tenista
/
Dexametasona
/
Iontoforesis
/
Antiinflamatorios
Tipo de estudio:
Clinical_trials
Límite:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Am J Sports Med
Año:
2003
Tipo del documento:
Article
País de afiliación:
Estados Unidos